PRNewswire/ -- (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today provided preliminary unaudited ...

Financial advisers often have a front-row seat to the Medicare mistakes their clients make. Too often, enrolling in Medicare ...

CEO Michael Intrator has recently extended his defense in CoreWeave’s adoption of a six-year useful life on its GPU assets.

More AI integration — but with better governance — and slimmer tech stacks are top of mind for experts in accounting ...

If you're thinking of becoming a financial analyst or an accountant, make sure you understand the differences between these ...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal ...

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance36% to 38% Annual YoY HIFU Revenue ...

Heron Therapeutics, Inc. (Nasdaq: HRTX) ('Heron” or the 'Company”), a commercial-stage biotechnology company, today announced ...

Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 ...

Although Nvidia has struggled due to AI bubble fears, NVDA stock managed to pop higher following a Buy signal. Fortunately, ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. For the ...

Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...